Agfa/Sterling deal clears hurdles

Article

Agfa’s proposed acquisition of Sterling Diagnostic Imaging received the go-ahead from regulatory authorities in the U.S. and Europe, the companies reported this month. Executives from the firms believe that the merger should be completed by the

Agfa’s proposed acquisition of Sterling Diagnostic Imaging received the go-ahead from regulatory authorities in the U.S. and Europe, the companies reported this month. Executives from the firms believe that the merger should be completed by the middle of May, pending shareholder approval (SCAN 1/20/99). Agfa’s spin-off from Bayer could come as soon as a month later, with Bayer setting a deadline of June 1 for the divestiture of its Mortsel, Belgium-based subsidiary, according to Bloomberg News.

Sterling of Greenville, SC, is also reportedly close to reaching a deal to sell off its Direct Radiography Corp. digital x-ray subsidiary, which is not part of the Agfa sale. Sources close to Sterling say that it has received bids from a number of prospective suitors for DRC, and plans to make a decision in the next several weeks.

Recent Videos
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Can AI Assessment of Longitudinal MRI Scans Improve Prediction for Pediatric Glioma Recurrence?
A Closer Look at MRI-Guided Adaptive Radiotherapy for Monitoring and Treating Glioblastomas
Incorporating CT Colonography into Radiology Practice
What New Research Reveals About Computed Tomography and Radiation-Induced Cancer Risk
What New Interventional Radiology Research Reveals About Treatment for Breast Cancer Liver Metastases
New Mammography Studies Assess Image-Based AI Risk Models and Breast Arterial Calcification Detection
Can Deep Learning Provide a CT-Less Alternative for Attenuation Compensation with SPECT MPI?
Employing AI in Detecting Subdural Hematomas on Head CTs: An Interview with Jeremy Heit, MD, PhD
Related Content
© 2025 MJH Life Sciences

All rights reserved.